期刊文献+

Anthraquinones of Cassiae Semen alleviate lipid accumulation in obesity by regulating brown adipose tissue and liver function

原文传递
导出
摘要 Objective:Cassiae Semen(CS,Juemingzi in Chinese)is a widely used traditional Chinese medicine with a variety of pharmacological effects.This study aimed to investigate the potential therapeutic effects and molecular mechanisms of anthraquinones of CS(AQS)for adiposity.Methods:The chemical components of the AQS were determined using high-performance liquid chromatography(HPLC).Network pharmacology analysis was used to predict potential anti-obesity targets of action for AQS.We constructed high fat with high sugar water diet-induced obese mice and observed their body weight and whole-body lipid metabolism to evaluate the efficacy of AQS in promoting lipid metabolism.Subsequently,the epidermal temperature at the brown adipose tissue(BAT)before and after cold stimulation was observed and the expression of lipid metabolism-related genes in the liver and BAT tissues was detected to clarify the mechanism of action of AQS.Results:Network pharmacology analysis showed that AQS was involved in the regulation of liver and adipose tissue function under obesity.Pathological and biochemical results showed that AQS reduced lipid accumulation in the liver and adipose tissue induced by an unhealthy diet.With the increase of cold tolerance,the volume and weight of BAT were increased by AQS,suggesting that it regulated the body heat production dominated by BAT.After AQS treatment,the levels of genes related to uncoupling protein1(UCP1)-mediated adaptive thermogenesis in BAT tissues and lipid metabolism in the liver were also increased,which further proved that AQS activated BAT function to promote lipid metabolism in the whole body.Conclusion:This study revealed the pharmacological effects of AQS,thereby providing a scientific basis for regulating BAT thermogenesis and liver lipid metabolism to alleviate obesity and providing clues for further exploring the application of natural active ingredients in the treatment of metabolismrelated diseases.
出处 《Chinese Herbal Medicines》 2025年第3期488-499,共12页 中草药(英文版)
基金 supported by grants from the Fundamental Research Funds for the Central Universities(No.2023-JYB-JBZD-046) National Key Research,Development Program on Modernization of Traditional Chinese Medicine(No.2022YFC3502100) the National High-Level Talents Special Support Program High-level traditional Chinese medicine key subjects construction project of National Administration of Traditional Chinese Medicine-Chinese Medicine Epidemic Disease(No.zyyzdxk-2023264)。
  • 相关文献

参考文献4

二级参考文献73

共引文献188

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部